Insulin resistance can lead to hyperinsulinemia, which can directly activate insulin-like growth factor-1 (IGF-1) receptor, or inhibit IGF-binding protein (IGFBP) to increase the bioavailability of IGF-1 to the IGF-1 receptor [44]. This evidence concerns the gene IGF1 and hyperinsulinism.